Sangamo Therapeutics (SGMO) Assets Average (2016 - 2025)
Historic Assets Average for Sangamo Therapeutics (SGMO) over the last 17 years, with Q3 2025 value amounting to $93.1 million.
- Sangamo Therapeutics' Assets Average fell 884.88% to $93.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $93.1 million, marking a year-over-year decrease of 884.88%. This contributed to the annual value of $133.5 million for FY2024, which is 6332.17% down from last year.
- According to the latest figures from Q3 2025, Sangamo Therapeutics' Assets Average is $93.1 million, which was down 884.88% from $91.9 million recorded in Q2 2025.
- In the past 5 years, Sangamo Therapeutics' Assets Average registered a high of $907.8 million during Q1 2021, and its lowest value of $91.9 million during Q2 2025.
- Moreover, its 5-year median value for Assets Average was $382.8 million (2023), whereas its average is $416.7 million.
- As far as peak fluctuations go, Sangamo Therapeutics' Assets Average surged by 4860.51% in 2021, and later tumbled by 7100.8% in 2024.
- Over the past 5 years, Sangamo Therapeutics' Assets Average (Quarter) stood at $747.2 million in 2021, then decreased by 22.61% to $578.2 million in 2022, then plummeted by 66.71% to $192.5 million in 2023, then plummeted by 44.7% to $106.4 million in 2024, then fell by 12.54% to $93.1 million in 2025.
- Its Assets Average stands at $93.1 million for Q3 2025, versus $91.9 million for Q2 2025 and $93.9 million for Q1 2025.